Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists
Authors:
Open Access
- 1 June 2025
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Translational Internal Medicine
- Vol. 13 (3) , 201-210
Abstract
For more than two decades, peripheral administration of GLP-1 or GLP-1 receptor (GLP-1R) agonist (GLP-1RA) curbs appetite and reduce body weight gain in animal models. More importantly, the body weight lowering effect has been effectively observed in clinical practice. There is no doubt that the target sites for GLP-1 or GLP-1RAs to exert those functions are located in the brain. It, however, remains controversy on exactly how these drugs access their targets in the brain. Here, we have discussed literatures on whether peripheral GLP-1 or GLP-1RAs enters the brain via crossing the blood-brain barrier, or the blood cerebrospinal fluid barrier, or given circumventricular organs. We have then commented the view or opinion that peripheral GLP-1RAs may exert their brain functions via organ-organ communications without entering the brain.Keywords
This publication has 117 references indexed in Scilit:
- International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious AwardsCardiovascular Drugs and Therapy, 2024
- Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or ObesityJAMA Internal Medicine, 2024
- Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early PregnancyJAMA Internal Medicine, 2024
- Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brainBrain Structure and Function, 2020
- Tanycyte‐like cells form a blood–cerebrospinal fluid barrier in the circumventricular organs of the mouse brainJournal of Comparative Neurology, 2013
- The Blood–Cerebrospinal Fluid Barrier: Structure and Functional Significance2010
- Distribution of leptin‐sensitive cells in the postnatal and adult mouse brainJournal of Comparative Neurology, 2009
- Glucagonlike peptide 1: A newly discovered gastrointestinal hormoneGastroenterology, 1994
- Pancreatic and intestinal processing of proglucagon in manDiabetologia, 1987
- Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gutFEBS Letters, 1987